Page last updated: 2024-08-16

temozolomide and mannitol

temozolomide has been researched along with mannitol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Boockvar, JA; Burkhardt, JK; Riina, HA; Shin, BJ1
Choi, C; Kim, HM; Kim, HT; Kim, NK; Kim, OJ; Oh, SH; Park, J; Shon, J1
Choi, C; Kang, SH; Kim, HM; Kim, HT; Kim, NK; Kim, OJ; Oh, SH; Park, J; Shon, J1
Alter, RA; Boockvar, JA; Chakraborty, S; Demopoulos, A; Filippi, CG; Fralin, S; Kulason, KO; Langer, DJ; Ortiz, R; Pramanik, B; Ray, A; Schneider, JR; Tan, K; Wong, T1

Reviews

1 review(s) available for temozolomide and mannitol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for temozolomide and mannitol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series.
    Neurosurgery clinics of North America, 2012, Volume: 23, Issue:2

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Blood-Brain Barrier; Brain Neoplasms; Cetuximab; Dacarbazine; Female; Glioblastoma; Humans; Infusions, Intra-Arterial; Male; Mannitol; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Temozolomide; Treatment Outcome

2012
Additional increased effects of mannitol-temozolomide combined treatment on blood-brain barrier permeability.
    Biochemical and biophysical research communications, 2018, 03-04, Volume: 497, Issue:2

    Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Capillary Permeability; Cell Line; Dacarbazine; Drug Synergism; Humans; Male; Mannitol; Rats; Rats, Sprague-Dawley; Temozolomide; Tight Junction Proteins

2018
The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model.
    Cytotherapy, 2018, Volume: 20, Issue:6

    Topics: Animals; Chronic Disease; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Disease Models, Animal; Doublecortin Protein; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Male; Mannitol; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Nerve Regeneration; Rats; Rats, Sprague-Dawley; Stroke; Temozolomide; Treatment Outcome

2018
Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastoma.
    Journal of experimental therapeutics & oncology, 2018, Volume: 12, Issue:3

    Topics: Angiography, Digital Subtraction; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Blood-Brain Barrier; Brain Neoplasms; Cerebral Angiography; Cetuximab; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Craniotomy; Dacarbazine; Dose Fractionation, Radiation; Female; Glioblastoma; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Mannitol; Middle Aged; Temozolomide; Treatment Outcome

2018